摘要 |
<p>This invention relates to the use of compounds of formula (I) for the manufacture of a medicament useful for modulating alpha2 subtype GABAA receptors. The invention further relates to novel heteocyclic compounds and pharmaceutical compositions containing said compounds. In addition the invention relates to the treatment of depression, an anxiety disorder, a psychiatric disorder, a learning or cognitive disorder, a sleep disorder, a convulsive or seizure disorder or pain.</p> |
申请人 |
F. HOFFMANN-LA ROCHE AG;LOUGHHEAD, DAVID, GARRETT;NOVAKOVIC, SANJA;O'YANG, COUNDE;PUTMAN, DAVID, GEORGE;SOTH, MICHAEL |
发明人 |
LOUGHHEAD, DAVID, GARRETT;NOVAKOVIC, SANJA;O'YANG, COUNDE;PUTMAN, DAVID, GEORGE;SOTH, MICHAEL |